Industry news that matters to you.  Learn more

Archives for October 2015

SCIEX Partners with University of Manchester to Develop Biomarker Discovery Centre and Multi-Omics Centre for Precision Medicine

SCIEX, a global leader in life science analytical technologies, has today announced that The University of Manchester, UK, has invested in a large suite of high-end SCIEX mass spectrometers for targeted and next-generation proteomics for its new Stoller Biomarker Discovery Centre. With SCIEX’s SWATH® Acquisition technologies, the Centre will be one of the biggest clinical proteomics facilities in the world. It will focus on industrializing proteomics research, and spearhead a series of biomarker development projects and international collaborations.

Profil Institute Unites Leading Experts in Biomarker Discovery and Clinical Research to Address the Medical Challenges of NAFLD/NASH

Profil Institute for Clinical Research, a clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today a collaboration of experts in biomarker discovery and clinical research in the fields of metabolism, diabetes and obesity to address the medical challenges of NAFLD and NASH.

Regulus Achieves All Research Milestones in Collaboration with Biogen to Identify microRNA Biomarkers for Multiple Sclerosis

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that it has earned a fourth milestone payment in its collaboration with Biogen (NASDAQ: BIIB) related to progress in the companies’ research collaboration to identify microRNAs as biomarkers for multiple sclerosis (“MS”). To earn the milestone, Regulus’ microMarkersSM division used its robust technology platform and bioinformatics expertise to analyze the treatment effects of a Biogen relapsing MS drug on circulating microRNA profiles previously identified by Regulus.

ACD Releases New Generation of RNAscope Products for RNA Biomarker Analysis in FFPE Tissue

Advanced Cell Diagnostics Inc. (ACD), the market leader in tissue-based RNA analysis tools for molecular pathology, has announced the release of its next version RNAscope® in situ hybridization (ISH) assay – RNAscope 2.5.

SRI International’s Tumor Glycome Laboratory Finds Carbohydrate Biomarkers to Target Breast Cancers

The field of precision medicine acknowledges the wide variation among people and diseases. A group at SRI Biosciences, a division of SRI International, has taken another step in the direction of specific cancer diagnostics and therapy, showing for the first time that carbohydrate molecules that determine blood type can also be used to detect different forms of breast cancer, including some triple-negative breast cancer tumors.